"10.1371_journal.pone.0148077","plos one","2016-02-03T00:00:00Z","Wouter B Vehmeijer; Vigdis Magnusdottir; Thorunn S Eliasdottir; Sveinn Hakon Hardarson; Nicoline E Schalij-Delfos; Einar Stefánsson","Department of Ophthalmology, University of Leiden, Leiden University Medical Center, Leiden, Netherlands; Department of Ophthalmology, Oslo University Hospital, Oslo, Norway; Department of Ophthalmology, University of Iceland, Landspítali University Hospital, Reykjavik, Iceland","Conceived and designed the experiments: VM SHH ES. Performed the experiments: WBV VM TSE. Analyzed the data: WBV SHH. Contributed reagents/materials/analysis tools: ES. Wrote the paper: WBV VM TSE SSH NES ES.","The authors of this manuscript have the following competing interests: Co-authors ES and SHH are involved as stockholders in the company Oxymap ehf., which designed the software algorithm. ES is on the board of Oxymap ehf. The company originated from research that both were (and are) involved in. Optos plc. has provided the Department of Ophthalmology, Landspitali, Reykjavik with the Optomap 200Tx. There are no patents, products in development or marketed products to declare. This does not alter the authors adherence to all the PLOS ONE policies on sharing data and materials, as detailed online in the guide for authors.","2016","02","Wouter B Vehmeijer","WBV",6,TRUE,3,3,2,6,TRUE,TRUE,FALSE,0,NA,FALSE
